Table S2 from PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy
收藏NIAID Data Ecosystem2026-05-17 收录
下载链接：
https://figshare.com/articles/dataset/Table_S2_from_PQR309_Is_a_Novel_Dual_PI3K_mTOR_Inhibitor_with_Preclinical_Antitumor_Activity_in_Lymphomas_as_a_Single_Agent_and_in_Combination_Therapy/22463270
下载链接
链接失效反馈官方服务：
资源简介：
PQR309 activity, combinations of PQR309 with additional drugs, BCL2, MYC and TP53 status in lymphoma cell lines.
创建时间：
2018-01-01
